Literature DB >> 23499647

Eliminating canine rabies: the role of public-private partnerships.

Louise Taylor1.   

Abstract

Canine rabies has been eliminated from industrialized countries, but infected dogs remain the principal source of human infections in the developing world. Despite the availability of effective tools for prevention and post-exposure prophylaxis, canine rabies inflicts a heavy burden on the poorest people of Africa, Asia and Latin America, resulting in more than 60,000 deaths each year. Public-private partnerships offer a new approach to the challenge of eliminating canine rabies in the developing world, by bringing together stakeholders to share responsibilities and reduce costs. The leading partnership for rabies control, the Partners for Rabies Prevention, is an informal international group that includes representatives of major health organizations (WHO, PAHO, FAO, OIE), the European Commission, universities, nongovernmental organizations, the human and animal health industries, and private global health institutions. This article describes how the Partners for Rabies Prevention is working toward the global elimination of canine rabies. It forms part of a symposium in Antiviral Research on the elimination of canine rabies.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23499647     DOI: 10.1016/j.antiviral.2013.03.002

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  8 in total

Review 1.  Emerging and reemerging neglected tropical diseases: a review of key characteristics, risk factors, and the policy and innovation environment.

Authors:  Tim K Mackey; Bryan A Liang; Raphael Cuomo; Ryan Hafen; Kimberly C Brouwer; Daniel E Lee
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

2.  Elimination of human rabies in Goa, India through an integrated One Health approach.

Authors:  A D Gibson; G Yale; J Corfmat; M Appupillai; C M Gigante; M Lopes; U Betodkar; N C Costa; K A Fernandes; P Mathapati; P M Suryawanshi; N Otter; G Thomas; P Ohal; I Airikkala-Otter; F Lohr; C E Rupprecht; A King; D Sutton; I Deuzeman; Y Li; R M Wallace; R S Mani; G Gongal; I G Handel; M Bronsvoort; V Naik; S Desai; S Mazeri; L Gamble; R J Mellanby
Journal:  Nat Commun       Date:  2022-05-19       Impact factor: 17.694

3.  Molecular epidemiology of reemergent rabies in Yunnan Province, southwestern China.

Authors:  Hai-Lin Zhang; Yu-Zhen Zhang; Wei-Hong Yang; Xiao-Yan Tao; Hao Li; Ji-Chao Ding; Yun Feng; Du-Juan Yang; Juan Zhang; Jiang He; Xin-Xin Shen; Li-Hua Wang; Yun-Zhi Zhang; Miao Song; Qing Tang
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883

4.  Development of Dog Vaccination Strategies to Maintain Herd Immunity against Rabies.

Authors:  Ahmed Lugelo; Katie Hampson; Elaine A Ferguson; Anna Czupryna; Machunde Bigambo; Christian Tetteh Duamor; Rudovick Kazwala; Paul C D Johnson; Felix Lankester
Journal:  Viruses       Date:  2022-04-16       Impact factor: 5.818

Review 5.  Potential economic benefits of eliminating canine rabies.

Authors:  Stephanie Shwiff; Katie Hampson; Aaron Anderson
Journal:  Antiviral Res       Date:  2013-03-13       Impact factor: 5.970

Review 6.  From recognition to action: A strategic approach to foster sustainable collaborations for rabies elimination.

Authors:  Rany Octaria; Stephanie J Salyer; Jesse Blanton; Emily G Pieracci; Peninah Munyua; Max Millien; Louis Nel; Ryan M Wallace
Journal:  PLoS Negl Trop Dis       Date:  2018-10-25

7.  Typological analysis of public-private partnerships in the veterinary domain.

Authors:  Margot Galière; Marisa Peyre; Facundo Muñoz; Mariline Poupaud; Alain Dehove; François Roger; Isabelle Dieuzy-Labaye
Journal:  PLoS One       Date:  2019-10-31       Impact factor: 3.240

Review 8.  Current status of rabies and prospects for elimination.

Authors:  Anthony R Fooks; Ashley C Banyard; Daniel L Horton; Nicholas Johnson; Lorraine M McElhinney; Alan C Jackson
Journal:  Lancet       Date:  2014-05-11       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.